Delivers real time decision support tools to improve clinical outcomes in acute medical scenarios
MedyMatch has raised €1.8M across 1 funding round from 2 investors, most recently a Seed round in Mar 2016. Based in Tel Aviv, Israel; founded 2014; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-03-01 | Seed | €1.8M |
| Exigent Capital,Genesis Capital |
| View deal → |
